TY  - GEN
AU  - Widenfalk,J
AU  - Lipson,A
AU  - Jubran,M
AU  - Hofstetter,C
AU  - Ebendal,T
AU  - Cao,Y
AU  - Olson,L
TI  - Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury
SN  - 0306-4522
PY  - 2003///1110
KW  - Analysis of Variance
KW  - Angiogenesis Inducing Agents
KW  - administration & dosage
KW  - Angiogenesis Inhibitors
KW  - Angiostatins
KW  - Animals
KW  - Animals, Newborn
KW  - Antigens
KW  - metabolism
KW  - Astrocytes
KW  - Behavior, Animal
KW  - drug effects
KW  - Blood Vessels
KW  - Bromodeoxyuridine
KW  - pharmacokinetics
KW  - Cell Count
KW  - Cell Death
KW  - Cell Division
KW  - Cerebral Cortex
KW  - Disease Models, Animal
KW  - Dose-Response Relationship, Drug
KW  - Endothelial Growth Factors
KW  - genetics
KW  - Extracellular Matrix Proteins
KW  - Female
KW  - Gene Expression Regulation
KW  - Glial Fibrillary Acidic Protein
KW  - Humans
KW  - Immunohistochemistry
KW  - In Situ Hybridization
KW  - In Situ Nick-End Labeling
KW  - Indoles
KW  - Intercellular Signaling Peptides and Proteins
KW  - Lymphokines
KW  - Nerve Degeneration
KW  - drug therapy
KW  - Neurofilament Proteins
KW  - Neuropilin-1
KW  - Neuropilin-2
KW  - Peptide Fragments
KW  - Plasminogen
KW  - RNA, Messenger
KW  - Random Allocation
KW  - Rats
KW  - Rats, Sprague-Dawley
KW  - Receptors, Vascular Endothelial Growth Factor
KW  - Recovery of Function
KW  - physiology
KW  - Spinal Cord
KW  - cytology
KW  - Spinal Cord Injuries
KW  - Time Factors
KW  - Treatment Outcome
KW  - Vascular Endothelial Growth Factor A
KW  - Vascular Endothelial Growth Factor Receptor-1
KW  - Vascular Endothelial Growth Factors
KW  - Wound Healing
KW  - von Willebrand Factor
KW  - immunology
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1016/s0306-4522(03)00399-3
ER  -